For personal use. Only reproduce with permission from The Lancet. In September two independent human rights reports documented the extent and severity of discrimination, abuse, and marginalisation of people with HIV/AIDS in China. The first report was from the US-based Human Rights Watch (http://www.hrw.org/reports/ 2003/china0803/) and the second from the Beijing-based Aizhi Action Project (http://www.aizhi.org). Both reports describe how the Chinese government has actively hindered progress towards halting the epidemic, denied people access to treatment and care, prevented the exchange of information on HIV/AIDS, and promoted unlawfulness and corruption in many parts of the country.
Government officials were quick to denounce the reports, but a prominent Chinese AIDS expert openly agreed that the reports were accurate, and gave a comprehensive picture of the human rights injustices seen today. Yet, by contrast, earlier this year, China took unprecedented action to swiftly bring severe acute respiratory syndrome (SARS) under control. So why has the more widespread and dangerous HIV/AIDS epidemic not been treated in a similar way? And what lessons can be learned from China's experience with SARS?
To begin with, SARS was handled in much the same way as HIV. For example, there has been no formal investigation into the involvement of local authorities in the Hennan blood scandal, which has left more than 1 million people infected with HIV. The cover-up of the blood scandal in Hennan and the central provinces encouraged the cover up of SARS. There was impunity for officials in Hennan, which clearly sent a message to other officials that if you have an epidemic, keep it quiet. The fact that China held government officials accountable for lying about the SARS epidemic set a good standard, and now they should do the same for AIDS. The reports recommend that those responsible should be held accountable, and compensation and treatment be provided immediately to those who have contracted HIV/AIDS as a result of receiving contaminated blood.
Where the handling of SARS and HIV began to differ was when the economic consequences of SARS were realised. SARS, an airborne disease, moved quickly from the rural provinces of Guangdong to the urban centres of mainland China, and then worldwide. It had a very visible impact on China's trade and tourist industry. By contrast, HIV is largely confined to the poorer rural parts of the country, and is often associated with the more "expendable" communities of society. Although the economic toll of
HIV is yet to be really felt, the government may want to change its thinking about the unimportance of its rural communities. A recent World Bank report and another report from the States Information Centre in China point out that future economic growth will be severely constrained unless the country improves conditions in the impoverished regions. These improvements would include delivering better public services to poor localities, and providing greater financial support in rebuilding rural health-care systems, improving the quality of medical care, and offering insurance schemes, including protection against catastrophic illness like AIDS. Indeed, the SARS epidemic exposed China's inadequate public health-care infrastructure in the countryside. In the past 20 years, as the country has moved to a market economy, there has been a withdrawal of funds and incomplete reforms in rural areas, which has meant that the poor are expected to pay for services and treatment, but are often unable to do so.
Despite the many failings of China to confront its HIV problem head on, the human rights reports do highlight the successes of small-scale pilot prevention and education projects, and new positive policy statements emphasising the importance of non-discrimination in national action plans. What is needed now is legal reform to ensure these policies are implemented at a local level. But perhaps the most hopeful sign of all that China is slowly acknowledging the huge scale of the problem, is the country's bid for US$100 million in aid from the Global Fund to Fight AIDS, Tuberculosis, and Malaria. The application publicly acknowledges many facts about the epidemic for the first time, including where the government went wrong. It signals a significant step forward by the government to provide universal AIDS treatment and care. Approval of the fund will be decided in October. It is unclear whether the human rights reports will complicate the bid, although it is hoped that international donors will include human rights guarantees in their working agreements in China.
There is no doubt that China has far greater economic resources today than it did when the first case of HIV/AIDS was diagnosed in 1985. But as China opens its doors to more foreign investment and trade, and the migration of rural communities to urban areas increases, a rising toll of HIV could still halt the rise of this "tiger" economy.
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